F&S Interactive Associates
Pregnancy outcomes after oral and injectable ovulation induction in women with infertility with a low antimüllerian hormone level compared with those with a normal antimüllerian hormone level
Ongoing pregnancy was comparable between low and normal antimullerian hormone with oral antiestrogen ovulation induction treatment. Decreased ongoing pregnancy but decreased multi-fetal gestations was observed with gonadotropin treatment for low antimullerian hormone patients.
Longitudinal semen parameter assessments and live birth: variability and implications for treatment strategies
Semen parameters are critical for couples undergoing ovulation induction/intrauterine insemination, whereas only low morphology was important to live birth after in vitro fertilization, providing evidence about which parameters are the most relevant in which settings.
Triggering with 1,500 IU of hCG plus FSH compared to a standard human chorionic gonadotropin trigger dose for oocyte competence in in vitro fertilization cycles: a randomized, double-blinded, controlled noninferiority trial
Compared to the standard human chorionic gonadotropin dose, triggering with 1,500 IU human chorionic gonadotropin plus 450 IU follicle-stimulating hormone produced noninferior oocyte competence in in vitro fertilization.
Latest Content
Endometrial gene expression differences in women with coronavirus disease 2019
Seventy-five percent of women with coronavirus disease 2019 (COVID-19) exhibit altered endometrial expression of genes involved in response to viruses and cytokine inflammation, highlighting their involvement in the COVID-19 pathway.